Pharvaris Ownership | Who Owns Pharvaris?
Pharvaris Ownership Summary
Pharvaris is owned by 14.76% institutional investors, 9.49% insiders, and 75.75% retail investors. General atlantic is the largest institutional shareholder, holding 13.96% of PHVS shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 2.50% of its assets in Pharvaris shares.
PHVS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Pharvaris | 14.76% | 9.49% | 75.75% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
General atlantic | 7.53M | 13.96% | $144.37M |
Fmr | 5.40M | 10.00% | $103.43M |
Foresite capital management iv | 4.40M | 8.15% | $84.31M |
Venbio partners | 4.29M | 7.95% | $82.23M |
Viking global investors lp | 3.65M | 6.77% | $70.03M |
Bain capital life sciences investors | 3.30M | 6.12% | $63.33M |
Vr adviser | 3.22M | 5.97% | $61.73M |
Deerfield management company, l.p. (series c) | 2.02M | 3.74% | $38.67M |
Commodore capital lp | 1.91M | 3.54% | $36.64M |
Novo | 1.73M | 3.20% | $33.07M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Foresite capital management iv | 4.40M | 77.49% | $84.31M |
Venbio partners | 4.29M | 48.17% | $82.23M |
Bain capital life sciences investors | 3.30M | 7.45% | $63.33M |
General atlantic | 7.53M | 5.14% | $144.37M |
Vr adviser | 3.22M | 4.24% | $61.73M |
5am venture management | 797.60K | 3.65% | $15.29M |
Commodore capital lp | 1.91M | 2.69% | $36.64M |
Octagon capital advisors lp | 778.00K | 2.45% | $14.91M |
Novo | 1.73M | 2.00% | $33.07M |
Cormorant asset management, lp | 1.47M | 1.54% | $28.11M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Soleus capital management | 814.65K | 0.98% | 216.48K |
Fmr | 5.40M | 0.01% | 189.71K |
Octagon capital advisors lp | 778.00K | 2.45% | 157.53K |
Price t rowe associates inc /md/ | 443.90K | 0.00% | 118.41K |
Woodline partners lp | 44.51K | 0.01% | 44.51K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ecor1 capital | - | - | -900.00K |
Citadel advisors | 14.47K | 0.00% | -223.83K |
Vr adviser | 3.22M | 4.24% | -175.48K |
Marshall wace, llp | - | - | -59.01K |
Sphera funds management | 388.18K | 1.35% | -51.11K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Woodline partners lp | 44.51K | 0.01% | 44.51K | $853.33K |
Palumbo wealth management | 10.22K | 0.07% | 10.22K | $195.94K |
Point72 asset management | 7.92K | 0.00% | 7.92K | $151.85K |
Cubist systematic strategies | 3.34K | 0.00% | 3.34K | $63.95K |
Citigroup | 543.00 | - | 543.00 | $10.41K |
Sold Out
Holder | Change |
---|---|
Adar1 capital management | -2.00K |
Ghisallo capital management | -11.25K |
Jump financial | -11.70K |
Crestline management, lp | -15.82K |
Y-intercept (hong kong) | -15.88K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 15 | -70.59% | 7,958,755 | -82.33% | 14 | 0.21% | 9 | -71.88% | 2 | -66.67% |
Sep 30, 2024 | 51 | 41.67% | 45,045,428 | 4.74% | 83 | 1.31% | 32 | 113.33% | 6 | -33.33% |
Jun 30, 2024 | 36 | 2.86% | 43,008,763 | 1.37% | 79 | 1.21% | 15 | -16.67% | 9 | - |
Mar 31, 2024 | 35 | -2.78% | 42,425,740 | 4.12% | 81 | 0.82% | 18 | -40.00% | 9 | 125.00% |
Dec 31, 2023 | 36 | 71.43% | 40,745,703 | 40.18% | 99 | 1.96% | 30 | 233.33% | 4 | -33.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 1.36M | 2.50% | 4.36K |
Fidelity Growth Compy Commingled Pl O | 1.24M | 2.29% | - |
Fidelity Growth Company Fund | 998.89K | 1.84% | - |
Fidelity Select Health Care | 746.75K | 1.38% | - |
Fidelity Small Cap Growth | 728.09K | 1.34% | - |
Fidelity Advisor Health Care I | 482.49K | 0.89% | - |
Fidelity Growth Company K6 | 304.39K | 0.56% | -4.36K |
Fidelity Series Growth Company | 285.24K | 0.53% | - |
Fidelity Small Cap Growth K6 | 271.33K | 0.50% | - |
Fidelity Select Biotechnology | 112.41K | 0.21% | - |
PHVS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools